Skip to Main Content

Paper Details

Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Cancer Gene Therapy
0
2021
ERK3, KRAS, MAPK6, NSCLC
Author NameAffiliation
Federico MariniInstitute of Medical Biostatistics, University Medical Center of the Johannes Gutenberg University Mainz
Federico MariniCenter for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz
  • 1 - 2

Datasets

Release 1.2